Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
Bora manufactures more than 20 commercial products for GSK at its Mississauga facility, supporting infectious disease, mental health, dermatology, & other critical therapeutic areas
OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bora Pharmaceuticals...